Cancer Publications 2016

26 Jan 2023
26 Jan 2023

  1. Abratt, R.P., 2016. Cost considerations in determining the affordability of adjuvant trastuzumab in breast cancer. South African Medical Journal, 106(10), p.981.

  2. Adeola, H.A. et al., 2016. In silico verification and parallel reaction monitoring prevalidation of potential prostate cancer biomarkers. Future Oncology, 12(1), pp.43–57.

  3. Adeola, H.A. et al., 2016. Novel potential serological prostate cancer biomarkers using CT100+ cancer antigen microarray platform in a multi-cultural South African cohort. Oncotarget, 7(12).

  4. Adler, D.H. et al., 2016. Cumulative Impact of HIV and Multiple Concurrent Human Papillomavirus Infections on the Risk of Cervical Dysplasia. Advances in Virology, 2016, pp.1–5.

  5. Ai, R. et al., 2016. NDRG1 overexpression promotes the progression of esophageal squamous cell carcinoma through modulating Wnt signaling pathway. Cancer Biology & Therapy, 17(9), pp.943–954.

  6. Amoury, M. et al., 2016. A novel approach for targeted elimination of CSPG4-positive triple-negative breast cancer cells using a MAP tau-based fusion protein. International Journal of Cancer, 139(4), pp.916–927.

  7. Amoury, M. et al., 2016. Granzyme B-based cytolytic fusion protein targeting EpCAM specifically kills triple negative breast cancer cells in vitro and inhibits tumor growth in a subcutaneous mouse tumor model. Cancer Letters, 372(2), pp.201–209.

  8. Amoury, M. et al., 2016. Photoimmunotheranostic agents for triple-negative breast cancer diagnosis and therapy that can be activated on demand. Oncotarget, 7(34).

  9. Barranco, J.A.J. et al., 2016. Gradual reduction of testosterone using a gonadotropin-releasing hormone vaccination delays castration resistance in a prostate cancer model. Oncology Letters, 12(2), pp.963–970.

  10. Begré, L. et al., 2016. Is human herpesvirus 8 infection more common in men than in women? Systematic review and meta-analysis. International Journal of Cancer, 139(4), pp.776–783.

  11. Billson, J., van der Merwe, F.H. & Soeters, R.P., 2016. Current South African clinical Practice in Debulking Surgery for Ovarian Cancer. International Journal of Gynecological Cancer, 26(8), pp.1428–1433.

  12. Bohlius, J. et al., 2016. Incidence of AIDS-defining and Other Cancers in HIV-positive Children in South Africa. The Pediatric Infectious Disease Journal, 35(6), pp.e164–e170.

  13. Chavez-Galan, L. et al., 2016. Tumor Necrosis Factor and Its Receptors Are Crucial to Control Mycobacterium bovis Bacillus Calmette-Guerin Pleural Infection in a Murine Model. The American Journal of Pathology, 186(9), pp.2364–2377.

  14. Chuang, L.T. et al., 2016. Sister Society Meeting on Global Education Development and Collaboration. International Journal of Gynecological Cancer, 26(6), pp.1186–1188.

  15. COHERE, 2016. Changing Incidence and Risk Factors for Kaposi Sarcoma by Time Since Starting Antiretroviral Therapy: Collaborative Analysis of 21 European Cohort Studies. Clinical Infectious Diseases, 63(10), pp.1373–1379.

  16. Dzobo, K. et al., 2016. Cancer Stem Cell Hypothesis for Therapeutic Innovation in Clinical Oncology? Taking the Root Out, Not Chopping the Leaf. OMICS: A Journal of Integrative Biology, 20(12), pp.681–691.

  17. Dzobo, K. et al., 2016. Wharton’s Jelly-Derived Mesenchymal Stromal Cells and Fibroblast-Derived Extracellular Matrix Synergistically Activate Apoptosis in a p21-Dependent Mechanism in WHCO1 and MDA MB 231 Cancer CellsIn Vitro. Stem Cells International, 2016, pp.1–17.

  18. Ebrahim, S. et al., 2016. High Burden of Human Papillomavirus (HPV) Infection among Young Women in KwaZulu-Natal, South Africa C. Meyers, ed. PLOS ONE, 11(1), p.e0146603.

  19. Fagan, J.J. et al., 2016. Educational workshops with graduates of the University of Cape Town Karl Storz Head and Neck Surgery Fellowship Program: a model for collaboration in outreach to developing countries. Springer Plus, 5(1), pp. 1652

  20. Firnhaber, C. et al., 2016. Prospective One Year Follow Up of HIV Infected Women Screened for Cervical Cancer Using Visual Inspection with Acetic Acid, Cytology and Human Papillomavirus Testing in Johannesburg South Africa M. L. Tornesello, ed. PLOS ONE, 11(1), p.e0144905.

  21. Harishankar, MK. et al., 2016. Association of Notch4 with metastasis in human oral squamous cell carcinoma. Life Sciences, 156, pp.38–46.

  22. Hilton, T.L. & Hosking, K., 2016. Endoprosthetic treatment of primary bone sarcomas with pathological fractures. SA Orthopaedic Journal, 15(2).

  23. Jonas, E., 2016. Aspects of treatment of colorectal cancer liver metastases in the 21st century. South African Gastroenterology Review, 14(1), pp.25-28.  

  24. Katsidzira, L. et al., 2016. The incidence and histo-pathological characteristics of colorectal cancer in a population based cancer registry in Zimbabwe. Cancer Epidemiology, 44, pp.96–100.

  25. Kgatle, M.M. et al., 2016. Prostate Cancer: Epigenetic Alterations, Risk Factors, and Therapy. Prostate Cancer, 2016, pp.1–11.

  26. Kgatle, M.M., Setshedi, M. & Hairwadzi, H.N., 2016. Hepatoepigenetic Alterations in Viral and Nonviral-Induced Hepatocellular Carcinoma. BioMed Research International, 2016, pp.1–13.

  27. Kriek, J.-M. et al., 2016. Female genital tract inflammation, HIV co-infection and persistent mucosal Human Papillomavirus (HPV) infections. Virology, 493, pp.247–254.

  28. Kundiona, I. & Fagan, J.J., 2016. Consequences and complications of surgery for tumours of the pre- versus post-styloid parapharyngeal spaces in 41 patients. Clinical Otolaryngology, 42(4), pp.886–888. http://dx.doi.org/10.1111/coa.12745

  29. Lennard, K.S., Goosen, R.W. & Blackburn, J.M., 2016. Bacterially-Associated Transcriptional Remodelling in a Distinct Genomic Subtype of Colorectal Cancer Provides a Plausible Molecular Basis for Disease Development A. Goel, ed. PLOS ONE, 11(11), p.e0166282.

  30. Lilienthal, N. et al., 2016. A Novel Recombinant Anti-CD22 Immunokinase Delivers Proapoptotic Activity of Death-Associated Protein Kinase (DAPK) and Mediates Cytotoxicity in Neoplastic B Cells. Molecular Cancer Therapeutics, 15(5), pp.971–984.

  31. Mbatani, N. et al., 2016. Performance of an Human Papillomavirus Test in Samples From Women With Histolopathologically Confirmed Invasive Cervical Cancer. Journal of Lower Genital Tract Disease, 20(2), pp.151–153.

  32. Mbulawa, Z.Z.A. et al., 2016. Xpert human papillomavirus test is a promising cervical cancer screening test for HIV-seropositive women. Papillomavirus Research, 2, pp.56–60.

  33. Mladenov, R. et al., 2016. CD64-directed microtubule associated protein tau kills leukemic blasts ex vivo. Oncotarget, 7(41), pp. 67166-67174.

  34. Moodley, J. et al., 2016. An overview of cancer research in South African academic and research institutions, 2013 - 2014. South African Medical Journal, 106(6), p.607.

  35. Moodley, J. et al., 2016. Understanding pathways to breast cancer diagnosis among women in the Western Cape Province, South Africa: a qualitative study. BMJ Open, 6(1), p.e009905.

  36. Müller, E.E. et al., 2016. The prevalence of human papillomavirus infections and associated risk factors in men-who-have-sex-with-men in Cape Town, South Africa. BMC Infectious Diseases, 16(1).

  37. Odusote, O. et al., 2016. Reaction to chemotherapy: a focus on Asparaginase. Current Allergy & Clinical Immunology, 29(4), pp. 232-234.

  38. Oskrochi, G. et al., 2016. An Application of the Multivariate Linear Mixed Model to the Analysis of Shoulder Complexity in Breast Cancer Patients. International Journal of Environmental Research and Public Health, 13(3), p.274.

  39. Papasavvas, E. et al., 2016. High-risk oncogenic HPV genotype infection associates with increased immune activation and T cell exhaustion in ART-suppressed HIV-1-infected women. OncoImmunology, 5(5), p.e1128612.

  40. Pietrocola, F., et al., 2016. Caloric Restriction Mimetics Enhance Anticancer Immunosurveillance. Cancer Cell, 30(1), pp. 147-160.

  41. Portier, CJ. Et al., 2016. Differences in the carcinogenic evaluation of glyphosate between the International Agency for Research on Cancer (IARC) and the European Food Safety Authority (EFSA). Journal of Epidemiology and Community Health, 70(8), pp.741-745.

  42. Rice, T.W. et al., 2016. Recommendations for clinical staging (cTNM) of cancer of the esophagus and esophagogastric junction for the 8th edition AJCC/UICC staging manuals. Diseases of the Esophagus, 29(8), pp.913–919.

  43. Roberts, R. et al., 2016. A morphological and immunohistochemical evaluation of gastric carcinoma in the Western Cape province of South Africa. South African Journal of Surgery, 54(1), pp. 15-21.

  44. Santesso, N. et al., 2016. World Health Organization Guidelines for treatment of cervical intraepithelial neoplasia 2-3 and screen-and-treat strategies to prevent cervical cancer. International Journal of Gynecology and Obstetrics, 132(3), pp. 252-258.

  45. Sartorius, B. et al., 2016. Carbohydrate intake, obesity, metabolic syndrome and cancer risk? A two-part systematic review and meta-analysis protocol to estimate attributability. BMJ Open, 6(1), p.e009301.

  46. Sengayi, M. et al., 2016. Record linkage to correct under-ascertainment of cancers in HIV cohorts: The Sinikithemba HIV clinic linkage project. International Journal of Cancer, 139(6), pp.1209–1216.

  47. Sewram, V. et al., 2016. Tobacco and alcohol as risk factors for oesophageal cancer in a high incidence area in South Africa. Cancer Epidemiology, 41, pp.113–121.

  48. Shires, K. & Wienand, K., 2016. Cancer testis antigen MAGE C1 can be used to monitor levels of circulating malignant stem cells in the peripheral blood of multiple myeloma patients. Journal of Cancer Research and Clinical Oncology, 142(11), pp.2383–2396.

  49. Skevaki, C. et al., 2016. Immune biomarkers in the spectrum of childhood noncommunicable diseases. Journal of Allergy and Clinical Immunology, 137(5), pp.1302–1316.

  50. Smith, M. et al., 2016. The cytotoxicity of garlic-related disulphides and thiosulfonates in WHCO1 oesophageal cancer cells is dependent on S-thiolation and not production of ROS. Biochimica et Biophysica Acta (BBA) - General Subjects, 1860(7), pp.1439–1449.

  51. Sobnach, S. et al., 2016. Primary seromucinous cystadenocarcinoma of the mesentery. South African Journal of Surgery, 54(3), pp.44-45.

  52. Stelma, T. et al., 2016. Targeting nuclear transporters in cancer: Diagnostic, prognostic and therapeutic potential. IUBMB Life, 68(4), pp.268–280.

  53. Stringhini, S. et al., 2016. The social patterning of risk factors for noncommunicable diseases in five countries: evidence from the modeling the epidemiologic transition study (METS). BMC Public Health, 16(1).

  54. Tamura, R.E. et al., 2016. GADD45α and γ interaction with CDK11p58 regulates SPDEF protein stability and SPDEF-mediated effects on cancer cell migration. Oncotarget, 7(12).

  55. Tanser, F. et al., 2016. Kaposi Sarcoma Risk in HIV-Infected Children and Adolescents on Combination Antiretroviral Therapy From Sub-Saharan Africa, Europe, and Asia. Clinical Infectious Diseases, p.ciw519.

  56. Thomford, N.E. et al., 2016. African Lettuce (Launaea taraxacifolia) Displays Possible Anticancer Effects and Herb–Drug Interaction Potential by CYP1A2, CYP2C9, and CYP2C19 Inhibition. OMICS: A Journal of Integrative Biology, 20(9), pp.528–537.

  57. Toft-Petersen, M. et al., 2016. Unravelling the relevance of CLEC12A as a cancer stem cell marker in myelodysplastic syndrome. British Journal of Haematology, 175(3), pp.393–401.

  58. Van der Watt, P.J. et al., 2016. Targeting the Nuclear Import Receptor Kpn 1 as an Anticancer Therapeutic. Molecular Cancer Therapeutics, 15(4), pp.560–573.

  59. Van Wyk, C. et al., 2016. Knowledge regarding basic concepts of hereditary cancers, and the available genetic counselling and testing services: A survey of general practitioners in Johannesburg, South Africa. South African Medical Journal, 106(3), p.268.

  60. Von Felbert, V. et al., 2016. A specific photoimmunotheranostics agent to detect and eliminate skin cancer cells expressing EGFR. Journal of Cancer Research and Clinical Oncology, 142(5), pp.1003–1011.

  61. Williams, D.R., Mohammed, S.A. & Shields, A.E., 2016. Understanding and effectively addressing breast cancer in African American women: Unpacking the social context. Cancer, 122(14), pp.2138–2149.

  62. Willmer, T. et al., 2016. The T-box transcription factor 3 is a promising biomarker and a key regulator of the oncogenic phenotype of a diverse range of sarcoma subtypes. Oncogenesis, 5(2), pp.e199–e199.

  63. Woitok, M. et al., 2016. The efficient elimination of solid tumor cells by EGFR-specific and HER2-specific scFv-SNAP fusion proteins conjugated to benzylguanine-modified auristatin F. Cancer Letters, 381(2), pp.323–330.